http://archive.fast-edgar.com/20260924/AR22R22GZ22RQ2Z2222C22YSRTDREZ223282
Filed on: September 24, 2026
http://archive.fast-edgar.com/20260924/A922L222ZC2239YI222Q2Z424FQ82K22Z282
Filed on: September 24, 2026
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 24, 2026
1933 ACT FILE NO. 333-214796
1940 ACT FILE NO. 811-23214
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-1A
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ☒ Pre-Effective Amendment No. ☐ Post-Effective Amendment No. 543 ☒ and/or ... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities... (continue reading...)
Nuveen AA-BBB CLO ETF
SUPPLEMENT DATED SEPTEMBER 24, 2026
TO THE PROSPECTUS DATED NOVEMBER 28, 2025
Himani Trivedi has announced that she will retire from Nuveen on June 30, 2027. She will continue to serve as a portfolio manager of the Nuveen AA-BBB CLO ETF (the “Fund”) until October 31, 2026.
Effective as of September 24, 2026, Stephen Virgilio will be named a portfolio manager of the Fund and Joshua Grumer will continue to serve as portfolio manager for... (continue reading...)
More SEC Filings
View Older Stories-
Form PRER14A Utz Brands, Inc.
-
Form 485BXT GraniteShares ETF Trust
-
Form 6-K TAIWAN SEMICONDUCTOR For: Aug 31
-
Form 485BXT GraniteShares ETF Trust
-
Form EFFECT New Carlyle Credit Solut
-
Form EFFECT GeoVax Labs, Inc.
-
Form EFFECT J-Star Holding Co., Ltd.
-
Form C/A Craftee Tri-Channel Drop
-
Form EFFECT Hyperliquid Strategies
-
Form D NeoDomes, Inc.
-
Form 485BPOS iM Global Partner Funds
-
Form EFFECT Polomar Health Services,
-
Form 424B3 New Carlyle Credit Solut
-
Form EFFECT RUI Holdings Inc
-
Form 6-K SEQUANS COMMUNICATIONS For: Sep 24
-
Form EFFECT AGILENT TECHNOLOGIES,
-
Form EFFECT MapLight Therapeutics,
-
Form SF-1 WHEELING POWER CO
-
Form SF-1 APPALACHIAN POWER CO
-
Form 1-A XChange Ventures, LLC
-
Form EFFECT INTELLIGENT BIO SOLUTION
-
Form EFFECT Radiopharm Theranostics
-
Form QUALIF Park View OZ REIT Inc
-
Form 8-K Artificial Intelligence For: Sep 24
-
Form 8-K Jaguar Health, Inc. For: Sep 23
-
Form 144 Qfin Holdings, Inc. Filed by: Yan Andrew Y
-
Form 8-K GROUP 1 AUTOMOTIVE INC For: Sep 23
-
Form 8-K Kyverna Therapeutics, For: Sep 24
-
Form SC TO-I UTAH MEDICAL PRODUCTS Filed by: UTAH MEDICAL PRODUCTS INC
-
Form 6-K Caledonia Mining Corp For: Sep 24
-
Form F-4 Inobat B.V.
-
Form S-1/A Evolution Metals & Techn
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D LIONHEART HA SPV I, LP
-
Form 305B2 Viking Therapeutics,
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D Wander-x LLC
-
Form 6-K Lufax Holding Ltd For: Sep 23
-
Form 424B2 ROYAL BANK OF CANADA
-
Form N-2/A DoubleLine Yield Opportu
-
Form 424B2 JPMORGAN CHASE & CO
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form 10-K AtlasClear Holdings, For: Jun 30
-
Form 8-K Lantern Pharma Inc. For: Sep 23
-
Form 6-K Lion Group Holding Ltd For: Sep 23
-
Form 6-K MESOBLAST LTD For: Sep 24
-
Form 424B2 ROYAL BANK OF CANADA
-
Form D SGV48, A Series of SGV
-
Form 6-K Cellyan Biotechnology For: Sep 23
-
Form PRE 14A Solidion Technology Inc. For: Sep 23
